In conclusion, expression of ACVRL1 is not simply coupled to established pathways such as angiogenesis, but is also extended to a regulatory network of processes that affect both malignant cells and other cellular entities of the tumor microenvironment, specifically immune cells. The gene discussed is ACVRL1; the disease is neoplasm.